VUNO Med-LungCT AI Reviews & Product Details

VUNO Med®-LungCT AI™ is an advanced artificial intelligence solution designed to assist healthcare professionals in the detection and analysis of pulmonary nodules from chest CT scans. By leveraging cutting-edge AI algorithms, it enhances the accuracy and efficiency of lung disease diagnoses, providing critical data on nodule size, volume, and location. Key Features and Functionality: - Nodule Detection and Quantification: Identifies pulmonary nodules within chest CT images, offering precise measurements of their size and volume. - Comprehensive Nodule Information: Provides detailed data on nodule type, location, calcification, and spiculation, facilitating thorough assessments. - Lung-RADS Categorization: Automatically classifies nodules according to the Lung-RADS system, aiding in standardized reporting and management. - Longitudinal Tracking: Enables comparison of serial CT scans by matching baseline and follow-up images, assisting in monitoring nodule growth over time. - Integration with PACS: Seamlessly integrates results into Picture Archiving and Communication Systems (PACS) using GSPS objects, ensuring user convenience and streamlined workflow. Primary Value and User Benefits: VUNO Med®-LungCT AI™ addresses the critical need for early detection of lung diseases, particularly lung cancer, by providing rapid and accurate analysis of chest CT scans. Its high sensitivity and low false-positive rate reduce the likelihood of missed diagnoses, thereby improving patient outcomes. The solution's ability to deliver detailed nodule information and standardized categorization enhances diagnostic confidence and supports effective patient management. By integrating seamlessly into existing medical imaging workflows, it minimizes additional workload for radiologists, allowing for more efficient and accurate assessments.

Seller

Vuno

Discussions

VUNO Med-LungCT AI Community

Top-Rated Alternatives

View All Alternatives

G2 reviews are authentic and verified.

Here's how.

OB

OSAMA B.

Civil & Fitouts Engineer cum Designer

Mid-Market (51-1000 emp.)

10/27/2026

"Fast, Intuitive Lung-RADS AI That Streamlines LDCT Nodule Reporting"

4.5/5

What do you like best about VUNO Med-LungCT AI?

User Interface / User Experience: The user interface is very simple, intuitive and designed for seamless integration into typical reading workflow. Click of a button allows clinicians to see categorized outputs that are fully consistent with Lung-RADS criteria.

Integration: Smoothly integrates into typical hospital PACS infrastructure, AI marketplace or web-based reading platform without interfering with current workflow.

Performance: Fast performance — analysis and quantification of complicated low-dose chest CT (LDCT) scans in just 10 to 60 seconds to speed up the diagnosis process.

ROI: Provides excellent return on investment through significant reduction of the time spent on measurements, decrease of the possibility of mistakes made by humans and faster screening process.

Support/Onboarding: Comes with solid support and implementation assistance which allows easy transition to digital AI-assisted reading for radiology departments.

AI/Intelligence: Uses state-of-the-art deep learning algorithms to automatically detect, measure and characterize pulmonary nodules (size, volume, type, localization, calcification, spiculation) and track growth through serial CT scans. Review collected by and hosted on G2.com.

What do you dislike about VUNO Med-LungCT AI?

UI/UX Customization: Although the default structured report templates are highly detailed, it may sometimes become necessary to customize the custom layouts to suit the particular institution’s reporting process, although it may sometimes be slightly inflexible.

Integration Depth: The initial integration of the PACS into the old hospital infrastructure or into restricted firewalls may sometimes take additional configuration time.

Support/On-boarding Guides: The reason for this is because the software makes use of automatic volumetrics and Lung-RADS automated grading and therefore necessitates structured training for the staff. Review collected by and hosted on G2.com.

What problems is VUNO Med-LungCT AI solving and how is that benefiting you?

The Problem: Radiologists dealing with high throughput lung cancer screening often face the problem of eye strain, tedious manual measuring of nodules, large inter-observer variation in volumetric measurements of nodules, and the potential of overlooking small and subsolid ground glass nodules.

The Solution: VUNO Med-LungCT AI detects and measures pulmonary nodules automatically and provides Lung RADS reports instantaneously. This will be helpful to us in terms of decreasing our reading times, improved longitudinal tracking of nodules, and being able to detect early stage lung cancer which we can intervene at the right time. Review collected by and hosted on G2.com.

Validated ReviewerIncentivizedSource: G2 invite

MS

Matt S.

Global Leadership Panel

Mid-Market (51-1000 emp.)

10/13/2026

"A positive hands-on experience with a specialist review tool"

5/5

What do you like best about VUNO Med-LungCT AI?

I have personally operated VUNO Med-LungCT AI, and my overall experience has been very positive. My wider work includes analysing data, building dashboards and reviewing reports, so I approach a specialist tool with an emphasis on the usefulness of its outputs and the care needed to interpret them. What I value is its fit with that experienced, analytical approach. I am comfortable recommending it on the basis of my direct use. I would assess it within the intended workflow, with professional judgement remaining central to the review of the information. Review collected by and hosted on G2.com.

What do you dislike about VUNO Med-LungCT AI?

I do not have a specific product fault to describe from my own experience. My main qualification is the need to understand the context of the output before drawing a conclusion. I would not treat a favourable software experience as proof of diagnostic accuracy in every situation. For an experienced user, the relevant question is how the tool fits the work and how its output is assessed. My view remains positive, but I have not provided an independent clinical validation or a numerical accuracy assessment. Review collected by and hosted on G2.com.

What problems is VUNO Med-LungCT AI solving and how is that benefiting you?

My assessment comes from direct operation of VUNO Med-LungCT AI alongside an analytical approach to data and reports. It has been a positive fit for that work, and I value the role of its outputs in the review process. I have not measured a specific reduction in review time or established a patient-outcome improvement. The benefit I can substantiate here is qualitative: I have been very satisfied with using the tool in my professional work. Review collected by and hosted on G2.com.

Validated ReviewerSource: Organic